Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

What was recalled

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 45 mg for 6-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3473-03, UPC 3 00743 47303 2.

Recalling firm: AbbVie Inc
NDC code: 0074-3473-03
Origin: IL, United States
Initiated by: Voluntary: Firm initiated
FDA recall number: D-1288-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Leuprolide recalls

See all

Class III · Low risk Terminated Sep 12, 2023

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use…

Reason Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.

Tolmar, Inc. NDC 62935-753-75 D-1178-2023

Class II · Moderate risk Terminated Nov 7, 2014

Leuprolide 50 mcg/0.1 mL Micro Lupron Kit, 5Ml, Compounded Rx, Perry Drug Compounding Pharmacy, Overland Park, KS --- NDC…

Reason Lack of sterility assurance;All lots of sterile products compounded by the pharmacy that are within expiry were recalled due to concerns associated…

Perry Drug Inc. NDC 88888-1124-57 D-0262-2015

Class II · Moderate risk Terminated Mar 10, 2014